- Low bankruptcy risk (Altman Z-Score: 3.55)
- Bullish trend confirmed on both short and long timeframes
- +63.4% price growth over the last year
Red day on Wednesday for Denali Therapeutics Inc. stock after losing 0.797%
(Updated on Jul 22, 2026)
The Denali Therapeutics Inc. stock price fell by -0.797% on the last day (Wednesday, 22nd Jul 2026) from $23.83 to $23.64. During the last trading day the stock fluctuated 2.09% from a day low at $23.42 to a day high of $23.91. The price has been going up and down for this period, and there has been a -11.43% loss for the last 2 weeks. Volume has increased on the last day by 192 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $30.30 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $23.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 36.61% during the next 3 months and, with a 90% probability hold a price between $31.62 and $38.70 at the end of this 3-month period.
DNLI Signals & Forecast
A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -13.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Denali Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $23.15 and $23.45. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Denali Therapeutics Inc. stock
Denali Therapeutics Inc. finds support from accumulated volume at $22.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.490 between high and low, or 2.09%. For the last week, the stock has had daily average volatility of 4.15%.
Our recommended stop-loss: $22.41 (-5.22%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)
Trading Expectations (DNLI) For The Upcoming Trading Day Of Thursday 23rd
For the upcoming trading day on Thursday, 23rd we expect Denali Therapeutics Inc. to open at $23.66, and during the day (based on 14 day Average True Range), to move between $23.01 and $24.27, which gives a possible trading interval of +/-$1.26 (+/-5.49%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.49% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $22.65 (4.19%) than the resistance at $25.57 (8.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Denali Therapeutics Inc. stock A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Current score:
2.553
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 23, 2026 - $23.66 ( 0.0705%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
DNLI Performance
Trading levels for DNLI
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 24.15 | 2.14% |
| R2 | 23.96 | 1.35% |
| R1 | 23.84 | 0.86% |
| Price | 23.64 | |
| S1 | 23.47 | -0.721% |
| S2 | 23.35 | -1.21% |
| S3 | 23.17 | -2.00% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.89 | 9.52% |
| R2 | 25.72 | 8.80% |
| R1 | 25.57 | 8.16% |
| Price | 23.64 | |
| S1 | 22.65 | -4.19% |
| S2 | 20.41 | -13.66% |
| S3 | 18.64 | -21.15% |
FAQ
Click here for our free guide on how to buy Denali Therapeutics Inc. Stock.
Buy DNLI